Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
Rhea-AI Summary
Sanuwave (NASDAQ: SNWV) announced it will host a live conference call on Friday, August 7, 2026 at 8:30 AM (ET) to present its Q2 2026 financial results. Investors can join via toll-free or international dial-in, or through a webcast link, with materials on the company’s investor website and a replay available until August 21, 2026.
Positive
- None.
Negative
- None.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 06 | Q1 earnings call | Neutral | +4.6% | Scheduled conference call for Q1 2026 financial results on May 13 |
| Mar 20 | Q4 earnings call | Neutral | -1.6% | Scheduled conference call for Q4 and full-year 2025 results |
| Nov 03 | Q3 earnings call | Neutral | +0.3% | Scheduled conference call for Q3 2025 financial results |
| Aug 04 | Q2 earnings call | Neutral | -1.4% | Scheduled conference call for Q2 2025 financial results |
| May 05 | Q1 earnings call | Neutral | -1.2% | Scheduled conference call for Q1 2025 financial results |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-call scheduling notices produced mixed 24-hour reactions, while the tag-specific average move was +0.16%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 7, 2026, at 8:30 AM (ET) to present its Q2 2026 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-274-8461
Toll/International: 1-203-518-9814
Conference ID: SANUWAVE
OR click the link below to access the live webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1771327&tp_key=110b588de5
Materials for the conference call will be included on the Company’s website at
www.sanuwave.com/investors.
A replay will be made available through Friday, August 21, 2026:
Toll-Free: 1-844-512-2921
Toll/International: 1-412-317-6671
Replay Access ID: 11162356
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
investors@sanuwave.com
